(Total Views: 484)
Posted On: 05/01/2020 2:42:43 PM
Post# of 154013
Perhaps I heard wrong, but I recall NP saying on this CC that they enrolled about 45 of 75 in the (mid-moderate) phase 2 trial and that they could possibly review and submit interim results next Friday.
Like others have said, this is the first I've ever heard that the phase 2 had any intern result review provision. So maybe NP misspoke but I'd think he'd have a good handle on this type of stuff.
NP also went on to say something to the effect of performing a review sooner if the FDA was open to that, seemingly suggesting that these trial review timelines are negotiable.
Like others have said, this is the first I've ever heard that the phase 2 had any intern result review provision. So maybe NP misspoke but I'd think he'd have a good handle on this type of stuff.
NP also went on to say something to the effect of performing a review sooner if the FDA was open to that, seemingly suggesting that these trial review timelines are negotiable.
(0)
(0)
